Trials / Completed
CompletedNCT02571049
Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine
Randomized, Double-Blind, Crossover, Comparator Pilot Study of DFN-11 Injection (Strength A vs. Strength B) for Rapidly Escalating Migraine
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Dr. Reddy's Laboratories Limited · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Pilot study to compare the efficacy and safety of two strengths of injections of subcutaneous DFN-11 in subjects with rapidly escalating migraine headaches.
Detailed description
Pilot study to compare the proportion of subjects experiencing pain freedom at 60 minutes post-treatment between headache treated with Strength A of DFN-11 and Strength B of DFN-11
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DFN-11 | Sumatriptan 3 mg versus 6 mg |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-04-01
- Completion
- 2016-05-01
- First posted
- 2015-10-08
- Last updated
- 2019-02-26
- Results posted
- 2018-07-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02571049. Inclusion in this directory is not an endorsement.